Jobs / United States / Astrazeneca Pharmaceuticals Lp
Senior Director, Global Oncology RWD Platform
Astrazeneca Pharmaceuticals Lp · 🇺🇸 US - Gaithersburg - MD
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles15 certified filings for “Associate Director Oncology Outcomes Research” (Medical Scientists, Except Epidemiologists) in MD: $126k–$185k, median $140k. Most were filed at wage level II (47%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Astrazeneca Pharmaceuticals Lp
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →
About the role
Join the NextGen Sciences team, within AstraZeneca Global Medical Affairs’ Oncology Evidence Generation to Publications (EG2P) organization as a Senior Director, AstraZeneca Global Oncology RWD Platform, including the AZ Partnerships in Oncology Maximising real world evidence (APOLLO) platform. APOLLO is a key EG2P initiative to foster innovation in global real world data generation linked to AZ medical strategies and priorities. We're looking for a multidimensional individual who can drive the creation and maintenance of this multi-asset platform, including identification of potential new partners for data access, collection or analysis, development of standard operating procedures, and development of a roadmap to ensure APOLLO will support multiple use cases at launch, including insights gathering, internal decision making and evidence generation. This role is a phenomenal opportunity to contribute to AZ oncology portfolio by providing access to new sources of real world treatment patterns and outcomes in key tumor types across the globe. The Senior Director, Global Oncology RWD Platform is responsible for the development and maintenance of a new platform for global oncology real world data, and implementation of innovative approaches to support the generation of timely and impactful real world evidence across the AstraZeneca oncology portfolio. Typical Accountabilities: • This person will be responsible for multiple initiatives within NGS and EG2P, and therefore must be comfortable with ambiguity and able to flex across different workstreams, cross-functional teams and discussion topics. • Identify and assess potential new partners for potential inclusion in APOLLO and conduct feasibility assessments to ensure fit for purpose with APOLLO strategy of expanding access to real world oncology data • Develop and implement a Roadmap to prepare the organization for APOLLO RWD ingestion and utilization • Develop a communication plan for internal AZ partners, including Evidence Generation to Publications (EG2P), broader Global Medical Affairs organization, regional and local teams regarding APOLLO status • In collaboration with other EG2P or OBU teams, develop dashboards summarizing key metrics from APOLLO RWD sources for internal AZ partners • Create and implement strategies that drive the implementation of APOLLO, ensuring availability of timely and meaningful data to support AZ’s global oncology real world evidence needs. • Foster collaborative relationships with external experts to help shape future APOLLO initiatives • Provide leadership and mentoring to teams and individuals to upskill and develop future capabilities in line with AstraZeneca’s dedication to a culture of performance development and lifelong learning. • Ensure that all Medical and business activities are carried out in compliance with AZ standards, standard operating procedures, and external regulations. Essential Qualifications • Minimum 10 years experience in the pharmaceutical industry with advanced degree in epidemiology, outcomes research, statistics and/or related subject areas. • Demonstrated experience building real world data (RWD) assets and real world evidence (RWE) generation. • Deep understanding of the utilization of RWD for multiple use cases, and ability to guide decisions regarding data structure, inclusion criteria, etc, to support those use cases. • In-depth expertise with research methods for real world research, HEOR projects including pharmacoepidemiologic models. • Proven track record of using tools for data curation / abstraction of unstructured information from electronic health records • Strong verbal and written communication skills, particularly around research methods and use of RWD in global and local settings Desira